A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site
Clinical trial NCT03498521 · COMPLETED
Trial details
- NCT number
- NCT03498521
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-10
- Primary completion
- 2023-02-14
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.